News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Akzo Nobel N.V. (AKZOY) Menopause Treatment Denied U.S. Approval


6/2/2006 11:12:25 AM

AMSTERDAM, June 2 (Reuters) - Dutch chemical group Akzo Nobel NV (AKZO.AS: Quote, Profile, Research)(AKZOY.O: Quote, Profile, Research) said on Friday that the U.S. Food and Drug Administration has found the menopause treatment tibolone of its Organon unit "not approvable". "Although Organon is disappointed with the FDA's response, we will continue to be committed to this proven brand," Organon General Manager Toon Wilderbeek said in a statement.


Read at Reuters

comments powered by Disqus
Reuters
   
Menopause

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES